CDXC Insider Trading
Insider Ownership Percentage: 9.64%
Insider Buying (Last 12 Months): $21,395.52
Insider Selling (Last 12 Months): $312,136.59
ChromaDex Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 03/18/2025 08:53 PM ET
ChromaDex Insider Trading History
ChromaDex Institutional Trading History
Data available starting January 2016
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
Read More on ChromaDex
Today's Range
Now: N/A
52 Week Range
Now: N/A
Volume
554,788 shs
Average Volume
727,901 shs
Market Capitalization
$611.50 million
P/E Ratio
787.29
Dividend Yield
N/A
Beta
2.21
Who are the company insiders with the largest holdings of ChromaDex?